Latent Sensitization in a Mouse Model of Ocular Neuropathic Pain

Purpose Chronic ocular pain is poorly understood and difficult to manage. We developed a murine model of corneal surface injury (CSI)–induced chronic ocular neuropathic pain. The study focuses on changes in corneal nerve morphology and associated short- and long-term pain-like behavior after CSI. Methods CSI was induced in mice by local application of an alkali solution (0.75 N NaOH). Corneal nerve architecture, morphology, density, and length were studied. Eye-wiping was evaluated before and after CSI in response to hypertonic saline (2 M NaCl). Naltrexone (NTX) or Naloxone-methiodide (NLX-me), opioid receptor antagonists, were given subcutaneously (s.c., 3 mg/kg) or topically (eye drop, 100 μM), and then an eye-wiping test was performed. Results CSI caused partial corneal deinnervation followed by gradual reinnervation. Regenerated nerves displayed increased tortuosity, beading, and branching. CSI enhanced hypertonic saline-induced eye-wiping behavior compared to baseline or sham-injury (P < 0.01). This hypersensitivity peaked at 10 days and subsided 14 days after CSI. Administration of NTX, or NLX-me, a selective peripheral opioid antagonist, reinstated eye-wiping behavior in the injury group, but not in the sham groups (P < 0.05). Conclusions This study introduces a model of chronic ocular pain and corneal neuropathy following CSI. CSI induces central and peripheral opioid receptor-dependent latent sensitization (LS) that is unmasked by systemic or topical administration of opioid antagonists. Translational Relevance This model of chronic ocular pain establishes LS as a new inhibitory mechanism in the oculotrigeminal system and may be used for potential diagnostic and therapeutic interventions for ocular neuropathy.

[1]  Midori Toyama,et al.  Trigeminal nervous system sensitization by infraorbital nerve injury enhances responses in a migraine model , 2017, Cephalalgia : an international journal of headache.

[2]  D. Jacobs Diagnosis and Treatment of Ocular Pain: the Ophthalmologist’s Perspective , 2017, Current Ophthalmology Reports.

[3]  P. Hamrah,et al.  Neuropathic Corneal Pain: Approaches for Management. , 2017, Ophthalmology.

[4]  F. Gao,et al.  Alkali Burn Induced Corneal Spontaneous Pain and Activated Neuropathic Pain Matrix in the Central Nervous System in Mice , 2017, Cornea.

[5]  Ningfei Liu,et al.  Blockade of angiopoietin-2/Tie2 signaling pathway specifically promotes inflammation-induced angiogenesis in mouse cornea. , 2017, International journal of ophthalmology.

[6]  R. Dana,et al.  Mechanisms of Retinal Damage after Ocular Alkali Burns. , 2017, The American journal of pathology.

[7]  R. Mohan,et al.  Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis. , 2017, Biochemical and biophysical research communications.

[8]  E. A. Volpe,et al.  Inhibition of NLRP3 Inflammasome Pathway by Butyrate Improves Corneal Wound Healing in Corneal Alkali Burn , 2017, International journal of molecular sciences.

[9]  Pedram Hamrah,et al.  In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease. , 2017, The ocular surface.

[10]  P. Hamrah,et al.  Corneal Nerve and Epithelial Cell Alterations in Corneal Allodynia: An In Vivo Confocal Microscopy Case Series. , 2017, The ocular surface.

[11]  A. Ishigami,et al.  Citrullination of glial intermediate filaments is an early response in retinal injury , 2016, Molecular vision.

[12]  Yong-Jing Gao,et al.  Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice , 2016, Journal of Neuroinflammation.

[13]  C. Jayadev,et al.  Bowman Break and Subbasal Nerve Plexus Changes in a Patient With Dry Eye Presenting With Chronic Ocular Pain and Vitamin D Deficiency , 2016, Cornea.

[14]  J. Sahel,et al.  Ocular inflammation induces trigeminal pain, peripheral and central neuroinflammatory mechanisms , 2016, Neurobiology of Disease.

[15]  W. Feuer,et al.  Neuropathic Ocular Pain due to Dry Eye is Associated with Multiple Comorbid Chronic Pain Syndromes. , 2016, The journal of pain : official journal of the American Pain Society.

[16]  J. Toldi,et al.  Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion , 2015, The Journal of Headache and Pain.

[17]  J. Sahel,et al.  Combined 3DISCO clearing method, retrograde tracer and ultramicroscopy to map corneal neurons in a whole adult mouse trigeminal ganglion. , 2015, Experimental eye research.

[18]  A. Galor,et al.  Incomplete response to artificial tears is associated with features of neuropathic ocular pain , 2015, British Journal of Ophthalmology.

[19]  A. Kheirkhah,et al.  Autologous Serum Tears for Treatment of Photoallodynia in Patients with Corneal Neuropathy: Efficacy and Evaluation with In Vivo Confocal Microscopy. , 2015, The ocular surface.

[20]  D. Borsook,et al.  Ocular neuropathic pain , 2015, British Journal of Ophthalmology.

[21]  M. C. Acosta,et al.  What Causes Eye Pain? , 2015, Current Ophthalmology Reports.

[22]  B. Taylor,et al.  Latent Sensitization: A Model for Stress‐Sensitive Chronic Pain , 2015, Current protocols in neuroscience.

[23]  A. Galor,et al.  Neuropathic ocular pain: an important yet underevaluated feature of dry eye , 2015, Eye.

[24]  Hyun Soo Lee,et al.  Extraorbital Lacrimal Gland Excision: A Reproducible Model of Severe Aqueous Tear-Deficient Dry Eye Disease , 2014, Cornea.

[25]  W. Feuer,et al.  Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain , 2014, British Journal of Ophthalmology.

[26]  G. Comi,et al.  Ocular surface injury induces inflammation in the brain: in vivo and ex vivo evidence of a corneal-trigeminal axis. , 2014, Investigative ophthalmology & visual science.

[27]  M. C. Acosta,et al.  Corneal sensory nerve activity in an experimental model of UV keratitis. , 2014, Investigative ophthalmology & visual science.

[28]  D. Storm,et al.  Constitutive μ-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence , 2013, Science.

[29]  G. Kundt,et al.  Imaging and Quantification of Subbasal Nerve Plexus in Healthy Volunteers and Diabetic Patients with or without Retinopathy , 2013, PloS one.

[30]  D. Borsook,et al.  The corneal pain system. Part I: the missing piece of the dry eye puzzle. , 2012, The ocular surface.

[31]  Laure Gambardella,et al.  A Computational Tool for Quantitative Analysis of Vascular Networks , 2011, PloS one.

[32]  D. Borsook,et al.  Chronic (neuropathic) corneal pain and blepharospasm: Five case reports , 2011, PAIN®.

[33]  D. Lau,et al.  A robust model for simultaneously inducing corneal neovascularization and retinal gliosis in the mouse eye , 2011, Molecular vision.

[34]  R. Donahue,et al.  Tonic inhibition of chronic pain by neuropeptide Y , 2011, Proceedings of the National Academy of Sciences.

[35]  Zuguo Liu,et al.  A mouse dry eye model induced by topical administration of benzalkonium chloride , 2011, Molecular vision.

[36]  P. Durham,et al.  Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization , 2011, Molecular pain.

[37]  D. Bereiter,et al.  Behavioral and neurophysiological correlates of nociception in an animal model of photokeratitis , 2010, Neuroscience.

[38]  S. Raja,et al.  A partial L5 spinal nerve ligation induces a limited prolongation of mechanical allodynia in rats: An efficient model for studying mechanisms of neuropathic pain , 2010, Neuroscience Letters.

[39]  Gregory I. Elliott,et al.  Withaferin A Targets Intermediate Filaments Glial Fibrillary Acidic Protein and Vimentin in a Model of Retinal Gliosis* , 2010, The Journal of Biological Chemistry.

[40]  Paolo Fogagnolo,et al.  Corneal subbasal nerves changes in patients with diabetic retinopathy: an in vivo confocal study. , 2009, Investigative ophthalmology & visual science.

[41]  C. McGhee,et al.  In vivo confocal microscopy of human corneal nerves in health, in ocular and systemic disease, and following corneal surgery: a review , 2008, British Journal of Ophthalmology.

[42]  R. Ji,et al.  c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? , 2009, The open pain journal.

[43]  J. Ambati,et al.  Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth , 2009 .

[44]  I. Zagon,et al.  Topically applied naltrexone restores corneal reepithelialization in diabetic rats. , 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[45]  Carolyn G. Begley,et al.  The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[46]  V. Sheibani,et al.  Eye-wiping test: a sensitive animal model for acute trigeminal pain studies. , 2005, Brain research. Brain research protocols.

[47]  M. Dana,et al.  The controlled-environment chamber: a new mouse model of dry eye. , 2005, Investigative ophthalmology & visual science.

[48]  C. N. Honda,et al.  Silver nitrate cauterization: characterization of a new model of corneal inflammation and hyperalgesia in rat , 2003, Pain.

[49]  F. Kruse,et al.  Corneal nerves: structure, contents and function. , 2003, Experimental eye research.

[50]  C. Woolf,et al.  Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity , 1999, Nature Neuroscience.

[51]  C. Belmonte,et al.  Excitation by irritant chemical substances of sensory afferent units in the cat's cornea. , 1991, The Journal of physiology.

[52]  M. Abelson,et al.  Standard models of corneal injury using alkali-immersed filter discs. , 1989, Investigative ophthalmology & visual science.